Currently, this novel agent is in limited supply outside of clinical trials . Accessing it requires enrollment in a approved research trial, which is usually conducted at select medical facilities . https://glp-3-retatrutide-for-sa494965.actoblog.com/43100756/accessing-the-medication-access-where-to-get-a-glp-3-receptor-treatment